Dr. Shiv Rao co-founded Abridge in 2018 while practicing as a cardiologist, pairing his direct clinical experience with the machine-learning research background of co-founder Zachary Lipton. As CEO, Rao has grounded Abridge's product development in a clinician's-eye view of documentation burden, positioning the company's ambient AI scribe technology specifically around reducing physician burnout rather than as a generic transcription tool.
Rao has continued to frame Abridge's growth - now deployed across more than 250 major health systems - around the specific, measurable problem of clinical documentation time, arguing that giving time back to physician-patient interaction is a more durable value proposition than broader, less clinically specific AI healthcare claims.